1-4 of 4
Suoping Zhai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer

Antoinette R. Tan, Xiaowei Yang, Arlene Berman, Suoping Zhai, Alex Sparreboom, Allyson L. Parr, Catherine Chow, Jaime S. Brahim, Seth M. Steinberg, William D. Figg, Sandra M. Swain
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5038–5047.
https://doi.org/10.1158/1078-0432.CCR-04-0025
Published: 05 August 2004
View article titled, Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer
Open the PDF for Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast Cancer in another window
Journal Articles

A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma

Susan E. Bates, Susan Bakke, Min Kang, Robert W. Robey, Suoping Zhai, Paul Thambi, Clara C. Chen, Sheela Patil, Tom Smith, Seth M. Steinberg, Maria Merino, Barry Goldspiel, Beverly Meadows, Wilfred D. Stein, Peter Choyke, Frank Balis, William D. Figg, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4724–4733.
https://doi.org/10.1158/1078-0432.CCR-0829-03
Published: 21 July 2004
View article titled, A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma
Open the PDF for A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma in another window
Journal Articles

Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Steven D. Gore, Li-Jun Weng, William D. Figg, Suoping Zhai, Ross C. Donehower, George Dover, Michael R. Grever, Constance Griffin, Louise B. Grochow, Anita Hawkins, Kathleen Burks, Yelena Zabelena, Carole B. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 963–970.
Published: 01 April 2002
View article titled, Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia
Open the PDF for Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia in another window
Journal Articles

Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia

Steven D. Gore, Li-Jun Weng, Suoping Zhai, William D. Figg, Ross C. Donehower, George J. Dover, Michael Grever, Constance A. Griffin, Louise B. Grochow, Eric K. Rowinsky, Yelena Zabalena, Anita L. Hawkins, Kathleen Burks, Carole B. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2330–2339.
Published: 01 August 2001
View article titled, Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia
Open the PDF for Impact of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia in another window